The Hospital for Special Surgery has been awarded an $800,000 grant to conduct a Phase II clinical trial utilizing autologous (the patient’s own) stem cells to help mend rotator cuff tears. This sizable grant will be used to treat one of the most common musculoskeletal conditions, particularly in athletes. Surgical repair for rotator cuff tears leave patients with resilient discomfort and pain, and many patients re-tear the muscle and are unable to return to full capacity. Stem cells can ameliorate the treatment process by facilitating recovery. The trial will investigate the efficacy of stem cells in skeletal muscle and tendon tissue regeneration, as well as the reduction of inflammation.
With over 50 patients enrolled in this 2 year clinical trial, Dr. Mendias, the co-principal investigator and scientist at the Hospital states, "This study may be the first to determine if stem cells from a patient's own adipose tissue can improve outcomes after rotator cuff repair… We believe that the patients who receive [the stem cells] may see improved function and demonstrate improved tissue healing on both clinical imaging and tissue histological studies."
As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.